Investors experiencing financial loss due to Unicycive Therapeutics, Inc. (UNCY) should consider reaching out to Levi & Korsinsky regarding a potential Class Action lawsuit associated with the company.
Unicycive Therapeutics, Inc. is currently facing a lawsuit filed by Levi & Korsinsky, LLP, a renowned securities litigation firm with extensive expertise in the field. The lawsuit, which can be found at this link: Lawsuit Submission Form, alleges securities fraud and seeks to recover losses for investors who were adversely affected between March 29, 2024, and June 27, 2025.
The complaint, in part, alleges that the regulatory prospects for the oxylanthanum carbonate new drug application were overstated, and that public statements made by the defendants were materially false and misleading at all relevant times. Furthermore, it alleges that defendants overstated Unicycive's readiness and ability to satisfy the FDA's manufacturing compliance requirements.
Investors in Unicycive Therapeutics, Inc. have until October 14, 2025, to request appointment as lead plaintiff in the ongoing lawsuit. However, participation in the lawsuit does not require serving as a lead plaintiff to potentially receive compensation.
Levi & Korsinsky, LLP, a firm that has secured hundreds of millions of dollars for aggrieved shareholders over the past 20 years, is handling the case. The firm has a team of over 70 employees to serve clients and has a track record of winning high-stakes cases. In fact, for seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.
Investors interested in the lawsuit are encouraged to contact Joseph E. Levi, Esq. at [email protected] or (212) 363-7500. The class definition for the lawsuit is investors in Unicycive Therapeutics, Inc. It is important to note that there are no out-of-pocket costs or fees for class members in the lawsuit.
The lawsuit seeks to recover losses for investors who were adversely affected due to the alleged securities fraud. The plaintiffs in the lawsuit have been requested to designate lead plaintiffs before October 14, 2025.
For more information about the lawsuit, please visit the submission form linked above or contact Levi & Korsinsky, LLP directly.
Read also:
- Catastrophe at a U.S. Steel facility in Pennsylvania results in the loss of two lives. crucial details unveiled
- Manipulating Sympathy: Exploiting Victimhood for Personal Gain
- Prices remain a concern for the Germans
- Auto Industry Updates: Geotab, C2A, Deloitte, NOVOSENSE, Soracom, and Panasonic in Focus
%20should%20consider%20reaching%20out%20to%20Levi%20%26%20Korsinsky%20regarding%20a%20potential%20Class%20Action%20lawsuit%20associated%20with%20the%20company.){kind=link}